240 related articles for article (PubMed ID: 1698703)
1. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
Oka H; Kurioka N; Kim K; Kanno T; Kuroki T; Mizoguchi Y; Kobayashi K
Hepatology; 1990 Oct; 12(4 Pt 1):680-7. PubMed ID: 1698703
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
3. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein.
Cottone M; Turri M; Caltagirone M; Parisi P; Orlando A; Fiorentino G; Virdone R; Fusco G; Grasso R; Simonetti RG
J Hepatol; 1994 Dec; 21(6):1029-34. PubMed ID: 7535323
[TBL] [Abstract][Full Text] [Related]
4. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Llovet JM
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):29-35. PubMed ID: 16431301
[No Abstract] [Full Text] [Related]
6. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in liver cirrhosis. A prospective study.
Imberti D; Fornari F; Sbolli G; Buscarini E; Squassante L; Buscarini L
Scand J Gastroenterol; 1993 Jun; 28(6):540-4. PubMed ID: 7686686
[TBL] [Abstract][Full Text] [Related]
9. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
10. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
11. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
Singal AG; Conjeevaram HS; Volk ML; Fu S; Fontana RJ; Askari F; Su GL; Lok AS; Marrero JA
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):793-9. PubMed ID: 22374994
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
15. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).
Trevisani F; De Notariis S; Rapaccini G; Farinati F; Benvegnù L; Zoli M; Grazi GL; Del PP; Di N; Bernardi M;
Am J Gastroenterol; 2002 Mar; 97(3):734-44. PubMed ID: 11922571
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
17. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
18. [Should we screen for hepatocellular carcinoma?].
Trinchet JC; Ganne-Carrié N
Gastroenterol Clin Biol; 2006; 30(6-7):880-6. PubMed ID: 16885873
[No Abstract] [Full Text] [Related]
19. Transient spontaneous regression of hepatocellular carcinoma.
Magalotti D; Gueli C; Zoli M
Hepatogastroenterology; 1998; 45(24):2369-71. PubMed ID: 9951925
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
